Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells

Area of Science:

• Oncology
• Cancer Biology
• Metastasis Research

Background:

• Circulating tumor cells (CTCs) are crucial for cancer metastasis.
• Clustered CTCs exhibit a higher metastatic potential than single CTCs.
• The mechanisms driving CTC cluster shedding remain largely unknown.

Purpose of the Study:

• To investigate the biological factors influencing the shedding of CTC clusters.
• To understand the role of hypoxia in CTC cluster formation and metastasis.
• To evaluate the impact of anti-angiogenic and pro-angiogenic therapies on CTC cluster dynamics.

Main Methods:

• Dynamic labeling of breast cancer cells during tumor progression.
• Monitoring of CTCs (single vs. clusters) and their oxygenation status (hypoxia/normoxia).
• Assessment of metastasis formation following VEGF-targeting and pro-angiogenic treatments.

Main Results:

• The majority of shed CTC clusters were found to be hypoxic, unlike single CTCs.
• VEGF-targeting therapy reduced primary tumors but increased intra-tumor hypoxia, leading to more CTC cluster shedding and metastasis.
• Pro-angiogenic therapy increased primary tumor size but significantly reduced CTC cluster formation and metastasis.

Conclusions:

• Intra-tumor hypoxia is a key driver for the formation of highly metastatic CTC clusters.
• Pro-angiogenic therapy effectively suppresses metastasis by preventing the generation of CTC clusters.
• Targeting angiogenesis offers a potential strategy to inhibit metastasis through modulation of CTC cluster dynamics.